117 related articles for article (PubMed ID: 11216953)
41. [Effectiveness of long-term ACE-inhibition on pulmonary diffusion and ventilation-perfusion ratio in chronic heart failure: correlation with physical performance].
Guazzi M; Pontone G; Trevisi N; Lomanto M; Melzi G; Agostoni P
Ann Ital Med Int; 1998; 13(1):17-23. PubMed ID: 9642838
[TBL] [Abstract][Full Text] [Related]
42. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure.
Guazzi M; Tumminello G; Di Marco F; Fiorentini C; Guazzi MD
J Am Coll Cardiol; 2004 Dec; 44(12):2339-48. PubMed ID: 15607396
[TBL] [Abstract][Full Text] [Related]
43. Influences of sildenafil on lung function and hemodynamics in patients with chronic heart failure.
Guazzi M; Tumminello G; Di Marco F; Guazzi MD
Clin Pharmacol Ther; 2004 Oct; 76(4):371-8. PubMed ID: 15470337
[TBL] [Abstract][Full Text] [Related]
44. Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange.
Lamberto C; Nunes H; Le Toumelin P; Duperron F; Valeyre D; Clerici C
Chest; 2004 Jun; 125(6):2061-8. PubMed ID: 15189922
[TBL] [Abstract][Full Text] [Related]
45. Cardiomegaly as a possible cause of lung dysfunction in patients with heart failure.
Agostoni P; Cattadori G; Guazzi M; Palermo P; Bussotti M; Marenzi G
Am Heart J; 2000 Nov; 140(5):e24. PubMed ID: 11054632
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of efficacy and safety of losartan potassium in the treatment of mild to moderate hypertension as compared to enalapril maleate.
Shobha JC; Kumar TR; Raju BS; Kamath S; Rao M; Harwal ; Babu A; Bhaduri J
J Assoc Physicians India; 2000 May; 48(5):497-500. PubMed ID: 11273142
[TBL] [Abstract][Full Text] [Related]
47. Enalapril as initial and sole treatment in severe chronic heart failure with sodium retention.
Anand IS; Kalra GS; Ferrari R; Wahi PL; Harris PC; Poole-Wilson PA
Int J Cardiol; 1990 Sep; 28(3):341-6. PubMed ID: 2210899
[TBL] [Abstract][Full Text] [Related]
48. Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition.
Vescovo G; Dalla Libera L; Serafini F; Leprotti C; Facchin L; Volterrani M; Ceconi C; Ambrosio GB
Circulation; 1998 Oct; 98(17):1742-9. PubMed ID: 9788828
[TBL] [Abstract][Full Text] [Related]
49. Reduced diffusing capacity as an isolated finding in asbestos- and silica-exposed workers.
Garcia JG; Griffith DE; Williams JS; Blevins WJ; Kronenberg RS
Chest; 1990 Jul; 98(1):105-11. PubMed ID: 2163299
[TBL] [Abstract][Full Text] [Related]
50. A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
Bakris G; Sica D; Ram V; Fagan T; Vaitkus PT; Anders RJ
Am J Hypertens; 2002 Jan; 15(1 Pt 1):53-7. PubMed ID: 11824861
[TBL] [Abstract][Full Text] [Related]
51. Renin-Angiotensin-Aldosterone Signaling Inhibitors-Losartan, Enalapril, and Cardosten-Prevent Infarction-induced Heart Failure Development in Rats.
Kiss K; Fekete V; Pálóczi J; Sárközy M; Murlasits Z; Pipis J; Kheyfets IA; Dugina JL; Sergeeva SA; Epstein OI; Csonka C; Csont T; Ferdinandy P; Bencsik P
Altern Ther Health Med; 2016; 22(2):10-7. PubMed ID: 27036051
[TBL] [Abstract][Full Text] [Related]
52. Pulmonary membrane diffusing capacity and capillary blood volume measured during exercise from nitric oxide uptake.
Tamhane RM; Johnson RL; Hsia CC
Chest; 2001 Dec; 120(6):1850-6. PubMed ID: 11742912
[TBL] [Abstract][Full Text] [Related]
53. Exercise-induced pulmonary edema in heart failure.
Agostoni P; Cattadori G; Bianchi M; Wasserman K
Circulation; 2003 Nov; 108(21):2666-71. PubMed ID: 14581402
[TBL] [Abstract][Full Text] [Related]
54. Alveolar gas diffusion abnormalities in heart failure.
Guazzi M
J Card Fail; 2008 Oct; 14(8):695-702. PubMed ID: 18926442
[TBL] [Abstract][Full Text] [Related]
55. The alveolar to arterial oxygen partial pressure difference is associated with pulmonary diffusing capacity in heart failure patients.
Morosin M; Vignati C; Novi A; Salvioni E; Veglia F; Alimento M; Merli G; Sciomer S; Sinagra G; Agostoni P
Respir Physiol Neurobiol; 2016 Nov; 233():1-6. PubMed ID: 27374970
[TBL] [Abstract][Full Text] [Related]
56. Salmeterol improves fluid clearance from alveolar-capillary membrane in COPD patients: a pilot study.
Di Marco F; Guazzi M; Sferrazza Papa GF; Vicenzi M; Santus P; Busatto P; Piffer F; Blasi F; Centanni S
Pulm Pharmacol Ther; 2012 Feb; 25(1):119-23. PubMed ID: 22245487
[TBL] [Abstract][Full Text] [Related]
57. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
White WB; Sica DA; Calhoun D; Mansoor GA; Anders RJ
Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162
[TBL] [Abstract][Full Text] [Related]
58. Low pulmonary diffusing capacity in subjects with acute mountain sickness.
Ge RL; Matsuzawa Y; Takeoka M; Kubo K; Sekiguchi M; Kobayashi T
Chest; 1997 Jan; 111(1):58-64. PubMed ID: 8995993
[TBL] [Abstract][Full Text] [Related]
59. Pulmonary membrane diffusing capacity and capillary blood volume in tropical eosinophilia.
Vijayan V; Kuppurao KV; Venkatesan P; Sankaran K; Prabhakar R
Chest; 1990 Jun; 97(6):1386-9. PubMed ID: 2347223
[TBL] [Abstract][Full Text] [Related]
60. ACE-Inhibition Benefit on Lung Function in Heart Failure is Modulated by ACE Insertion/Deletion Polymorphism.
Contini M; Compagnino E; Cattadori G; Magrì D; Camera M; Apostolo A; Farina S; Palermo P; Gertow K; Tremoli E; Fiorentini C; Agostoni P
Cardiovasc Drugs Ther; 2016 Apr; 30(2):159-68. PubMed ID: 26847573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
